Received Jul 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | Z003579 | — |
a 2 month old was administered CAPVAXIVE; no adverse event; This spontaneous report was received from a medical assistant referring to a 2-month-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies, and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) Injection (lot #Z003579, expiration date: 07-Sep-2026) (168 mcg/ml) administered as prophylaxis (dose, and route of administration were not reported) (Product administered to patient of inappropriate age). No adverse effects were reported (no adverse event).
Comments: unknown